|RAD -- USA Stock|| |
USD 1.41 0.05 3.42%
holds recent Real Value
of $4.8605 per share. The prevailing price of the company is $1.41. Based on Macroaxis valuation methodology, the company appears to be under valued. Macroaxis determines value of Rite Aid
from analyzing the company fundamentals
such as Shares Outstanding
of 1.06B, Operating Margin
of 2.44% and Return On Equity of (29.94)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we support investing in undervalued entities and to dispose of overvalued entities since at some point stocks prices and their ongoing real values will merge together.
The drug sector of the market has recently been under pressure as Amazon is looking to enter the distribution aspect and this has all drug stores on edge. Rite Aid’s stock has been up slightly after the news of the sale but the stock has been pushed down greatly since the sale talks have begun.
Valuation Drivers Correlation
Net Income Per Employee Enterprise Value Market Capitalization
Rite Aid Corporation Valuation Data Drivers
Rite Aid Market Cap
Rite Aid Corporation is rated below average
in market capitalization category among related companies. Market capitalization
of Diversified Wholesale And Retail
industry is at this time estimated at about 322.14 Billion. Rite Aid adds roughly 1.56 Billion in market capitalization claiming only tiny portion of equities under Diversified Wholesale And Retail industry.